Insights into amoxicillin pharmacokinetics using physiology-based pharmacokinetic modelling
Abstract
ABSTRACT Amoxicillin is the most commonly used antibiotic globally. However, there is a relatively poor understanding of its pharmacokinetics, pharmacodynamics, and clinical pharmacology. We constructed a physiology-based pharmacokinetic (PBPK) model of amoxicillin to gain deeper insights into the adequacy of amoxicillin regimens for the treatment of infections relevant to global health. We constructed an amoxicillin PBPK model in PK-Sim using known ADME and physicochemical parameters, in vitro characterized transporter kinetics of amoxicillin with OAT3, and time-concentration data from the published literature. Unknown parameters were fitted using a subset of available clinical pharmacokinetic data for training, before final validation with a holdout data set. Population simulations were performed using the final model for a range of amoxicillin regimens and contexts. The final amoxicillin PBPK model was high performing by fold-error metrics for both plasma and urinary concentrations. Simulations demonstrated all regimens achieved the 40%T>minimum inhibitory concentration (MIC) target for Streptococcus pneumoniae up to 1 mg/L and all except p.o. 500 mg amoxicillin q8h for the wild-type Haemophilus influenzae MIC distribution. The simulations also demonstrated high urinary amoxicillin exposures and evaluated the effects of inadequate active ingredient content, missed doses, and probenecid co-administration. This PBPK model gives the following insights into amoxicillin…
Read the paper
Related studies
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.